loadpatents
name:-0.03170108795166
name:-0.018789052963257
name:-0.0025620460510254
Singh; Shailesh Patent Filings

Singh; Shailesh

Patent Applications and Registrations

Patent applications and USPTO patent grants for Singh; Shailesh.The latest application filed is for "detecting cancer with anti-cxcl13 and anti-cxcr5 antibodies".

Company Profile
1.23.37
  • Singh; Shailesh - Powder Springs GA
  • Singh; Shailesh - Prospect KY US
  • Singh; Shailesh - Atlanta GA US
  • SINGH; SHAILESH - POWER SPRINGS GA
  • Singh; Shailesh - Bardonia NY
  • Singh; Shailesh - Mumbai IN
  • Singh; Shailesh - Sherwood OR
  • Singh; Shailesh - Beaverton OR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Detecting Cancer With Anti-cxcl13 And Anti-cxcr5 Antibodies
App 20200209248 - Lillard; James W. ;   et al.
2020-07-02
Methods For Prevention And Treatment Of Inflammation Using Anti-chemokine Antibodies
App 20160244518 - Lillard, JR.; James W. ;   et al.
2016-08-25
Detecting Cancer With Anti-cxcl16 And Anti-cxcr6 Antibodies
App 20160139130 - LILLARD, JR.; James W. ;   et al.
2016-05-19
Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration
Grant 9,233,120 - Lillard , et al. January 12, 2
2016-01-12
Detecting Cancer With Anti-cxcl13 And Anti-cxcr5 Antibodies
App 20150212092 - LILLARD, JR.; James W. ;   et al.
2015-07-30
Detecting Cancer With Anti-cxcl13 And Anti-cxcr5 Antibodies
App 20150126394 - LILLARD, JR.; James W. ;   et al.
2015-05-07
Nanoparticles for delivery of active agents
Grant 8,962,030 - Lillard , et al. February 24, 2
2015-02-24
Detecting cancer with anti-CCL25 and anti-CCR9 antibodies
Grant 8,658,377 - Lillard , et al. February 25, 2
2014-02-25
Methods for prevention and treatment of inflammation using anti-chemokine antibodies
Grant 8,580,261 - Lillard, Jr. , et al. November 12, 2
2013-11-12
Nanoparticles for delivery of active agents
Grant 8,568,784 - Lillard , et al. October 29, 2
2013-10-29
Methods For Prevention And Treatment Of Inflammation Using Anti-chemokine Antibodies
App 20130243761 - Lillard, JR.; James W. ;   et al.
2013-09-19
Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration
Grant 8,512,701 - Lillard , et al. August 20, 2
2013-08-20
Delivery System For Specifically Targeting Cancer Cells And Method Of Use Thereof
App 20130045162 - Lillard, JR.; James W. ;   et al.
2013-02-21
Methods For Prevention And Treatment Of Inflammation Using Anti-chemokine Antibodies
App 20120315272 - Lillard, JR.; James W. ;   et al.
2012-12-13
Methods for prevention and treatment of inflammation using anti-chemokine antibodies
Grant 8,318,170 - Lillard , et al. November 27, 2
2012-11-27
Nanoparticles for delivery of active agents
Grant 8,231,907 - Lillard , et al. July 31, 2
2012-07-31
Detecting Cancer With Anti-cxcl13 And Anti-cxcr5 Antibodies
App 20120135415 - LILLARD; James W. ;   et al.
2012-05-31
Anti-cxcl13 And Anti-cxcr5 Antibodies For The Prevention And Treatment Of Cancer And Cancer Cell Migration
App 20120128688 - LILLARD; James W. ;   et al.
2012-05-24
Detecting Cancer With Anti-ccl25 And Anti-ccr9 Antibodies
App 20120100554 - Lillard; James W. ;   et al.
2012-04-26
Anti-ccl25 And Anti-ccr9 Antibodies For The Prevention And Treatment Of Cancer And Cancer Cell Migration
App 20120100154 - LILLARD; James W. ;   et al.
2012-04-26
Detecting Cancer With Anti-cxcl16 And Anti-cxcr6 Antibodies
App 20120082993 - LILLARD; JAMES W. ;   et al.
2012-04-05
Anti-cxcl16 And Anti-cxcr6 Antibodies For The Prevention And Treatment Of Cancer And Cancer Cell Migration
App 20120064089 - Lillard; James W. ;   et al.
2012-03-15
Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
Grant 8,097,250 - Lillard , et al. January 17, 2
2012-01-17
Methods For Prevention And Treatment Of Inflammation Using Anti-chemokine Antibodies
App 20110287063 - Lillard, JR.; James W. ;   et al.
2011-11-24
Methods For Prevention And Treatment Of Inflammation Using Anti-chemokine Antibodies
App 20110280872 - LILLARD; James W. ;   et al.
2011-11-17
Methods For Prevention And Treatment Of Inflammation Using Anti-chemokine Antibodies
App 20110280871 - LILLARD; James W. ;   et al.
2011-11-17
Anti-chemokine And Associated Receptors Antibodies For Inhibition Of Growth Of Neoplasms
App 20110150982 - Lillard; James W. ;   et al.
2011-06-23
Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation
Grant 7,964,194 - Lillard, Jr. , et al. June 21, 2
2011-06-21
Anti-chemokine And Associated Receptors Antibodies For Inhibition Of Growth Of Neoplasms
App 20110123603 - LILLARD; James W. ;   et al.
2011-05-26
Anti-chemokine And Associated Receptors Antibodies For Inhibition Of Growth Of Neoplasms
App 20110091529 - Lillard; James W. ;   et al.
2011-04-21
Anti-chemokine And Associated Receptors Antibodies For Inhibition Of Growth Of Neoplasms
App 20110091528 - LILLARD; James W. ;   et al.
2011-04-21
Anti-chemokine And Associated Receptors Antibodies For Inhibition Of Growth Of Neoplasms
App 20110081408 - LILLARD; James W. ;   et al.
2011-04-07
Anti-chemokine And Associated Receptors Antibodies For Inhibition Of Growth Of Neoplasms
App 20110081406 - LILLARD; James W. ;   et al.
2011-04-07
Anti-chemokine And Associated Receptors Antibodies For Inhibition Of Growth Of Neoplasms
App 20110081407 - LILLARD; James W. ;   et al.
2011-04-07
Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
Grant 7,919,083 - Lillard, Jr. , et al. April 5, 2
2011-04-05
Novel Nanoparticles For Delivery Of Active Agents
App 20110052710 - LILLARD; James W. ;   et al.
2011-03-03
Novel Nanoparticles For Delivery Of Active Agents
App 20110052709 - Lillard; James W. ;   et al.
2011-03-03
Pantoprazole multiparticulate formulations
Grant 7,838,027 - Venkata Ramana Rao , et al. November 23, 2
2010-11-23
Orally Disintegrating Composition Of Zolmitriptan
App 20100179202 - Patnaik; Meenakshi ;   et al.
2010-07-15
Pantoprazole multiparticulate formulations
Grant 7,553,498 - Venkata Ramana Rao , et al. June 30, 2
2009-06-30
Pantoprazole multiparticulate formulations
Grant 7,550,153 - Venkata Ramana Rao , et al. June 23, 2
2009-06-23
Pantoprazole multiparticulate formulations
Grant 7,544,370 - Venkata Ramana Rao , et al. June 9, 2
2009-06-09
Distributed fiber optic sensor with location capability
Grant 7,514,670 - Anderson , et al. April 7, 2
2009-04-07
Novel nanoparticles for delivery of active agents
App 20070224280 - Lillard; James W. ;   et al.
2007-09-27
Pantoprazole multiparticulate formulations
App 20070196443 - Ramana Rao; Sripriya Venkata ;   et al.
2007-08-23
Pantoprazole multiparticulate formulations
App 20070196444 - Ramana Rao; Sripriya Venkata ;   et al.
2007-08-23
Distributed fiber optic sensor with location capability
App 20070096007 - Anderson; Duwayne ;   et al.
2007-05-03
Pantoprazole multiparticulate formulations
App 20070042033 - Venkata Ramana Rao; Sripriya ;   et al.
2007-02-22
Pantoprazole multiparticulate formulations
App 20050129761 - Venkata Ramana Rao, Sripriya ;   et al.
2005-06-16
Single sweep polarization dependent loss measurement
Grant 6,856,386 - Anderson , et al. February 15, 2
2005-02-15
Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation
App 20040191255 - Lillard, James W. JR. ;   et al.
2004-09-30
Single sweep polarization dependent loss measurement
App 20040184029 - Anderson, Duwayne R. ;   et al.
2004-09-23
Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
App 20040170628 - Lillard, James W. JR. ;   et al.
2004-09-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed